Chao H Sun

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

James E. Novak, S. Hemmerich, L. Szczech, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients

Yun Li, Li Li, Hua Yu, 2022, World journal of diabetes.